J
Jesse L. Goodman
Researcher at University of Minnesota
Publications - 58
Citations - 7574
Jesse L. Goodman is an academic researcher from University of Minnesota. The author has contributed to research in topics: Endothelium & Endothelial stem cell. The author has an hindex of 35, co-authored 57 publications receiving 7358 citations. Previous affiliations of Jesse L. Goodman include Center for Biologics Evaluation and Research & University of Maryland, Baltimore.
Papers
More filters
Journal ArticleDOI
A Controlled Trial of Fluconazole to Prevent Fungal Infections in Patients Undergoing Bone Marrow Transplantation
Jesse L. Goodman,Drew J. Winston,Ronald A. Greenfield,Pranatharthi H. Chandrasekar,Barry C. Fox,Herbert Kaizer,Richard K. Shadduck,Thomas C. Shea,Patrick J. Stiff,David J. Friedman,William G. Powderly,Jeffrey L. Silber,Harold W. Horowitz,Alan E. Lichtin,Steven N. Wolff,Mangan Kf,Samuel M. Silver,Daniel J. Weisdorf,Winston G. Ho,Gene S. Gilbert,Donald N. Buell +20 more
TL;DR: Prophylactic administration of fluconazole to recipients of bone marrow transplants reduces the incidence of both systemic and superficial fungal infections.
Journal ArticleDOI
Transmission of West Nile virus from an organ donor to four transplant recipients.
Martha Iwamoto,Daniel B. Jernigan,Antonio Guasch,Mary Jo Trepka,Carina Blackmore,Walter C. Hellinger,Si M. Pham,Sherif R. Zaki,Robert S. Lanciotti,Susan E. Lance-Parker,Carlos A. DiazGranados,Andrea G Winquist,Carl A Perlino,Steven T. Wiersma,Krista L Hillyer,Jesse L. Goodman,Anthony A. Marfin,Mary E. Chamberland,Lyle R. Petersen +18 more
TL;DR: The investigation of this cluster documents the transmission of West Nile virus by organ transplantation and suggests organ recipients receiving immunosuppressive drugs may be at high risk for severe disease after West Nileirus infection.
Journal ArticleDOI
Transmission of West Nile virus through blood transfusion in the United States in 2002.
Lisa N. Pealer,Anthony A. Marfin,Lyle R. Petersen,Robert S. Lanciotti,Peter L Page,Susan L. Stramer,Mary Grace Stobierski,Kimberly Signs,Bruce Newman,Hema Kapoor,Jesse L. Goodman,Mary E. Chamberland +11 more
TL;DR: Screening of potential donors with the use of nucleic acid-based assays for West Nile virus may reduce this risk of acquisition of the virus through transfused red cells, platelets, and fresh-frozen plasma.
Journal ArticleDOI
A Randomized, Double-Blind Comparative Trial Evaluating the Safety of Liposomal Amphotericin B versus Amphotericin B Lipid Complex in the Empirical Treatment of Febrile Neutropenia
TL;DR: In this double-blind study to compare safety of 2 lipid formulations of amphotericin B, neutropenic patients with unresolved fever after 3 days of antibacterial therapy were randomized to receive ABLC or L Amph, and infusional reactions were less frequent with ABLC, but chills/rigors were still higher.
Journal ArticleDOI
A Randomized and Blinded Multicenter Trial of High-Dose Fluconazole plus Placebo versus Fluconazole plus Amphotericin B as Therapy for Candidemia and Its Consequences in Nonneutropenic Subjects
John H. Rex,John H. Rex,Peter G. Pappas,Adolf W. Karchmer,Jack D. Sobel,John E. Edwards,Susan Hadley,Corstiaan Brass,Jose A. Vazquez,Stanley W. Chapman,Harold W. Horowitz,Marcus J. Zervos,David S. McKinsey,Jeannette Y. Lee,Timothy Babinchak,Robert W. Bradsher,John D. Cleary,David M. Cohen,Larry H. Danziger,Mitchell Goldman,Jesse L. Goodman,Eileen Hilton,Newton E. Hyslop,Daniel H. Kett,Jon E. Lutz,Robert H. Rubin,W. Michael Scheld,Mindy G. Schuster,Bryan P. Simmons,David K. Stein,Ronald G. Washburn,Linda Mautner,Teng-Chiao Chu,Helene Panzer,Rebecca B. Rosenstein,Jenia Booth +35 more
TL;DR: In nonneutropenic subjects, the combination of fluconazole plus AmB was not antagonistic compared with flu Conazole alone, and the combination trended toward improved success and more-rapid clearance from the bloodstream.